These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29927068)

  • 41. NMR-Assisted Molecular Docking Methodologies.
    Sturlese M; Bellanda M; Moro S
    Mol Inform; 2015 Aug; 34(8):513-25. PubMed ID: 27490497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic Studies on the Protocol and Criteria for Selecting a Covalent Docking Tool.
    Wen C; Yan X; Gu Q; Du J; Wu D; Lu Y; Zhou H; Xu J
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Essential considerations for using protein-ligand structures in drug discovery.
    Warren GL; Do TD; Kelley BP; Nicholls A; Warren SD
    Drug Discov Today; 2012 Dec; 17(23-24):1270-81. PubMed ID: 22728777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HCovDock: an efficient docking method for modeling covalent protein-ligand interactions.
    Wu Q; Huang SY
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36573474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Docking techniques in pharmacology: How much promising?
    Gupta M; Sharma R; Kumar A
    Comput Biol Chem; 2018 Oct; 76():210-217. PubMed ID: 30067954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementing QM in docking calculations: is it a waste of computational time?
    Adeniyi AA; Soliman MES
    Drug Discov Today; 2017 Aug; 22(8):1216-1223. PubMed ID: 28689054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantum chemical approaches: semiempirical molecular orbital and hybrid quantum mechanical/molecular mechanical techniques.
    Bryce RA; Hillier IH
    Curr Pharm Des; 2014; 20(20):3293-302. PubMed ID: 23947649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simulation of Ligand Transport in Receptors Using CaverDock.
    Hozzová J; Vávra O; Bednář D; Filipovič J
    Methods Mol Biol; 2021; 2266():105-124. PubMed ID: 33759123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of machine learning approaches for novel drug discovery.
    Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
    Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular interaction fingerprint approaches for GPCR drug discovery.
    Vass M; Kooistra AJ; Ritschel T; Leurs R; de Esch IJ; de Graaf C
    Curr Opin Pharmacol; 2016 Oct; 30():59-68. PubMed ID: 27479316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Forging the Basis for Developing Protein-Ligand Interaction Scoring Functions.
    Liu Z; Su M; Han L; Liu J; Yang Q; Li Y; Wang R
    Acc Chem Res; 2017 Feb; 50(2):302-309. PubMed ID: 28182403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Docking-based virtual screening of covalently binding ligands: an orthogonal lead discovery approach.
    Schröder J; Klinger A; Oellien F; Marhöfer RJ; Duszenko M; Selzer PM
    J Med Chem; 2013 Feb; 56(4):1478-90. PubMed ID: 23350811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Covalent docking in CDOCKER.
    Wu Y; Brooks Iii CL
    J Comput Aided Mol Des; 2022 Aug; 36(8):563-574. PubMed ID: 35984589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamic Docking: A Paradigm Shift in Computational Drug Discovery.
    Gioia D; Bertazzo M; Recanatini M; Masetti M; Cavalli A
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29165360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New generation of docking programs: Supercomputer validation of force fields and quantum-chemical methods for docking.
    Sulimov AV; Kutov DC; Katkova EV; Ilin IS; Sulimov VB
    J Mol Graph Model; 2017 Nov; 78():139-147. PubMed ID: 29055806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Task-Specific Scoring Functions for Predicting Ligand Binding Poses and Affinity and for Screening Enrichment.
    Ashtawy HM; Mahapatra NR
    J Chem Inf Model; 2018 Jan; 58(1):119-133. PubMed ID: 29190087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The compromise of virtual screening and its impact on drug discovery.
    Slater O; Kontoyianni M
    Expert Opin Drug Discov; 2019 Jul; 14(7):619-637. PubMed ID: 31025886
    [No Abstract]   [Full Text] [Related]  

  • 58. Is It Reliable to Use Common Molecular Docking Methods for Comparing the Binding Affinities of Enantiomer Pairs for Their Protein Target?
    Ramírez D; Caballero J
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Building a virtual ligand screening pipeline using free software: a survey.
    Glaab E
    Brief Bioinform; 2016 Mar; 17(2):352-66. PubMed ID: 26094053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantum Chemical Approaches in Structure-Based Virtual Screening and Lead Optimization.
    Cavasotto CN; Adler NS; Aucar MG
    Front Chem; 2018; 6():188. PubMed ID: 29896472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.